)
Elisabeth Nyakatura
Senior Associate Director, Antibody Engineering,
Tri-Institutional Therapeutics Discovery Institute, Inc.
Elisabeth is currently heading the Antibody Engineering team at the Tri-Institutional Therapeutic Discovery Institute (Tri-I TDI) in New York, bridging partnerships in academia and industry to develop antibody-based therapies. In this role, she oversees the generation and optimization of biologics drug candidates, leads therapeutic antibody discovery programs, and coaches a functional team of scientists and managers. Prior to joining TDI, Elisabeth was a Research Assistant professor at the Albert Einstein College of Medicine. Her work guided the development of antiviral antibodies. Elisabeth is passionate about identifying and implementing strategies to drive innovation and to improve drug development processes. She thrives to motivate people to push against barriers and to inspire upcoming generations to leave a positive impact on the world.